A single-center experience in the management of head and neck lymphangiomas.

A single-center experience in the management of head and neck lymphangiomas.:

Related Articles

A single-center experience in the management of head and neck lymphangiomas.

Oral Maxillofac Surg. 2020 Jan 20;:

Authors: Aluffi Valletti P, Brucoli M, Boffano P, Benech A, Toso A, Dell'Era V, Garzaro M

Abstract

INTRODUCTION: Lymphangiomas are relatively uncommon head and neck region lymphatic malformations. Although surgery can be still considered the mainstay of treatment, sclerotherapy by OK-432 is becoming a widespread treatment option. The aim of this article is to present and discuss the management and outcomes of a series of cases of lymphangiomas.

METHODS: All patients with lymphangiomas who were treated from 2010 to 2018 were reviewed. The following data were recorded: age, gender, subtype, staging, type of treatment, outcome, and recurrence.

RESULTS: Fifteen patients (9 females, 6 males) were included with 2 microcystic and 13 macrocystic lymphangiomas. Six patients underwent surgery with excision (5 with a complete success, one with a fair success), whereas the remaining 9 subjects underwent sclerotherapy by OK-432 (6 with a complete success, 3 with a fair success). No postoperative complications were observed.

CONCLUSIONS: All modes of treatment are important in properly selected patients affected by lymphangiomas. OK-432 therapy is a safe and effective option in the treatment of head and neck lymphangiomas.

PMID: 31960163 [PubMed - as supplied by publisher]